Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study
Silvana Galderisi, Marc D. Binder, Stefano Del Prato, et al.
European Psychiatry (2021) Vol. 64, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Evidence-based psychosocial interventions in schizophrenia: a critical review
Sergio Barlati, Gabriele Nibbio, Antonio Vita
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 3, pp. 131-139
Open Access | Times Cited: 22
Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal
Andrea Fiorillo, Norman Sartorius
Annals of General Psychiatry (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 71
Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations
Nicolette Stogios, Bailey Humber, Sri Mahavir Agarwal, et al.
Current Psychiatry Reports (2023) Vol. 25, Iss. 11, pp. 707-721
Closed Access | Times Cited: 32
Severe Mental Disorders and Cardiovascular Diseases
Martina Rojnić Kuzman, Sara Medved
(2025), pp. 221-235
Closed Access
Schizophrenia as a risk factor for cardiovascular and metabolic health outcomes: a comparative risk assessment
Suhailah Ali, Damian Santomauro, Alize J Ferrari, et al.
Epidemiology and Psychiatric Sciences (2023) Vol. 32
Open Access | Times Cited: 12
Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Psychiatry Research (2024) Vol. 340, pp. 116126-116126
Open Access | Times Cited: 4
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature
Giulia Maria Giordano, Francesco Brando, Pasquale Pezzella, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 18
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations
Antonio Vita, Sergio Barlati, Roberto Cavallaro, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives
Irene Calzavara‐Pinton, Gabriele Nibbio, Sergio Barlati, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 791-791
Open Access | Times Cited: 2
CYP2D6 Genetic Variation and Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis
Yanisa Wannasuphoprasit, Stig Ejdrup Andersen, María J. Arranz, et al.
Frontiers in Psychology (2022) Vol. 12
Open Access | Times Cited: 11
GLP-1 agonists: superior for mind and body in antipsychotic-treated patients?
Kateřina Horská, Jana Kučerová, Silje Skrede
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 9, pp. 628-638
Closed Access | Times Cited: 9
Association of hypertension, type 2 diabetes mellitus and dyslipidemia with the duration of inpatient treatments and recurrence of schizophrenia
Eva Kathrin Lamadé, Nicole Özer, Bernhard Schaupp, et al.
Journal of Psychosomatic Research (2023) Vol. 172, pp. 111436-111436
Open Access | Times Cited: 5
Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia
Andrea Amerio, Luca Magnani, Gabriele Arduino, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 7, pp. 1233-1247
Closed Access | Times Cited: 5
Employing graph attention networks to decode psycho-metabolic interactions in Schizophrenia
Hongyi Yang, Dian Zhu, Yanli Liu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115841-115841
Closed Access | Times Cited: 1
Recommendations of the treatment-resistant depression expert center network for promoting tobacco smoking cessation based on the results from the real-world FACE-TRD national cohort
Théo Korchia, Mélanie Faugère, Nicolas Suc, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 114, pp. 110479-110479
Open Access | Times Cited: 8
Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome
Anastasiia S. Boiko, Irina A. Mednova, Elena G. Kornetova, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1655-1655
Open Access | Times Cited: 5
Inter-relationships of risk factors and pathways associated with all-cause mortality in patients with chronic schizophrenia
Teng‐Hung Yu, Thung‐Lip Lee, Chin‐Feng Hsuan, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access
The influence of reward sensitivity on weight in treatment-resistant chronic schizophrenia
Isaac Jarratt Barnham, Youssuf Saleh, Masud Hussain, et al.
Spanish Journal of Psychiatry and Mental Health (2024)
Open Access
Mortality in a Moroccan psychiatric hospital
Chouaib Khlil, Nadia Attouche, Hafsa Choujaa, et al.
Middle East Current Psychiatry (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study
Pierre‐Michel Llorca, Philippe Nuss, É. Fakra, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Design and pilot evaluation of an evidence-based worksheet and clinician guide to facilitate nutrition counselling for patients with severe mental illness
Laura LaChance, Monique Aucoin, Kieran Cooley
BMC Psychiatry (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area
Grímur Høgnason Mohr, Carlo Alberto Barcella, Mia Klinten Grand, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access
Page 1

Scroll to top